Central Nervous System Diseases
154
31
36
80
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
28 trials with published results (18%)
Research Maturity
80 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.5%
10 terminated out of 154 trials
88.9%
+2.4% vs benchmark
11%
17 trials in Phase 3/4
35%
28 of 80 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 80 completed trials
Clinical Trials (154)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
Selective Activation of the Adrenomedullin Receptors in Migraine
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
Hypersensitivity to Amylin in Post-Traumatic Headache
Amylin-Induced Migraine Attacks Without Aura
Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes
Longitudinal Assessment of Protein Markers in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement
Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Upper Limb Recovery in Patients With Stroke
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age